je.st
news
OraSure Technologies, Inc. (OSUR) Lifted to "Buy" at Zacks Investment Research
2015-12-15 06:30:25| Biotech - Topix.net
The firm currently has a $7.25 price objective on the stock. Zacks Investment Research 's price target indicates a potential upside of 12.23% from the company's current price.
Tags: buy
research
investment
technologies
Category:Biotechnology and Pharmaceuticals
Latest from this category |
All news |
||||||||||||||||||||
|
|
||||||||||||||||||||